PLYMOUTH, MA – In response to the growing opioid epidemic impacting the South Shore, CleanSlate Addiction Treatment Centers has opened its eleventh center within Massachusetts at 110 Long Pond Road in Plymouth, MA. CleanSlate will be accepting new patients starting August 3rd, 2015.
Founded in 2009 to address to the growing opioid crisis facing Massachusetts, today CleanSlate is the largest, non-cash based provider of medication assisted treatment services with buprenorphine and extended release naltrexone in the Commonwealth.
As of May 23rd, Plymouth had averaged one opioid-related overdose per day thus far this year. In addition, Plymouth has suffered 11 opioid-related deaths in 2015 alone. Within Massachusetts, there are now on average 3 opioid-related deaths occurring each day.
CleanSlate’s assistance was requested by Beth Israel Deaconess Hospital-Plymouth. “They called us and asked us to come and work with them to help solve this problem,” says CleanSlate President, CEO, and Board Certified Addictionist Amanda Wilson, MD. “BID-Plymouth has been highly proactive in addressing the issue, and felt that CleanSlate could help bridge the huge gap that exists in the availability of longitudinal, quality outpatient care.”
“Too many Plymouth residents struggle with heroin addiction and finding appropriate treatment where they live,” says Beth Israel Deaconess Hospital-Plymouth President Peter Holden. “The opening of CleanSlate’s program provides a new level of hope for those who want treatment and for their families as well.”
“Confronting the opioid epidemic head-on requires extensive collaboration between providers, state agencies, and community advocacy groups,” says Dr. Wilson. “We are confident that, by working hand-in-hand with Plymouth community leaders, we will have a positive impact and ensure access to quality care for those struggling with addiction.”
About CleanSlate Centers
CleanSlate Centers was founded in 2009 in response to the growing opioid epidemic facing the country. A network of outpatient addiction treatment centers, CleanSlate provides compassionate, effective, medication assisted treatment and related therapies for patients who have addiction and associated disorders using the highest quality, evidence based practices.
In recognition of their innovation and effectiveness, CleanSlate’s treatment programs received the inaugural 2012 Science and Service Award for Office-based Opioid Treatment by the federal Substance Abuse and Mental Health Service Administration (SAMHSA.)
The WilMark Group